Elon Musk and his neurotech start-up are trialling brain-decoding implants


US entrepreneur Elon Musk and his tech start-up Neuralink have unveiled a new brain monitoring device that could one day enable paraplegics to use their thoughts to operate computers and smartphones. 

The new technology is based around a "sewing machine" robot that will be used to implant thousands of electrodes into the brain to monitor and stimulate neural activity.

Musk hosted an evening event earlier this month at the California Academy of Sciences where he and his team provided an overview of their research.

In theory, the new device could allow a computer system to detect and analyze brain activity in a way that translates into outputs such as “move a robotic arm 3 inches up and left and grab what’s there”. It could also stimulate the somatosensory cortex in a way that would make paralyzed patients feel as though they had touched something.

Experts have been impressed by the progress of the ambitious project. “Overall, the concept is impressive and so is the progress they’ve made,” said neurobiologist Andrew Schwartz of the University of Pittsburgh Medical Center, a pioneer in the technology. 

Yet there is still much work to be done. “A lot of this still seems to be conceptual”, Schwartz said. “It’s hard to tell what’s aspirational and what they’ve actually done”. 

There are significant concerns about the durability of the technology, and its potential to damage the brain. 

In his presentation, Musk has alluded to the fact that the electrodes implanted in the brain will eventually stop working and require replacement. Removal of the electrodes could be difficult, as they are attached to remarkably thin electrode-holding threads. 

There are also risks that the implants could cause trigger infection, or be the catalyst for a stroke, aneurysm or immune reaction in the patient. 

“The big risk, of course, is if something goes wrong… one more major adverse event could cause a stricter regulatory crackdown,” said Andrew Hires, a neurobiologist at the University of Southern California, whose research focuses on how the brain processes the sense of touch and emotion in the cortex.

Even still, Neuralink has said that it hopes to start tests on human subjects as early as next year. 

Xavier Symons is deputy editor of BioEdge




MORE ON THESE TOPICS | brain stimulation, elon musk, neuroethics, neuroscience

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus